4[1]Lok AS,Heathcote EJ.HoofnagleJH. Management of hepatitis B 2000 summary of a workshop[ J ]. Gastroenterology, 2001, 120: 1825- 1853.
5[2]Kuhns M, McNamara A. Campbell C.Perrillo R.antigen[J]. Gastroenterology 1992, 103: 1649 ～ 56.
6[3]Lok AS .Chronic hepatitis B [J] .N Engl J Med 2002,346:1682- 1683.
7[4]Chevillotte G,Durbec JP,Gerolami A, et al. Interaction between hepatitis B virus and alcohol consumption in liver cirrhosis[J]. An epidemiologic study. Gastroenterology 1983,85: 141 - 145.
8[6]Lok AS, Chyng HT,Liu VWS,et al.Long-term follow upof chronic hepatitis B patients treated with interferon alfa. Gastroenterology, 1993,105:1833 - 1838.
9[7]Cohard M,Poynard T,Mathurin P,Zarski JP.Prednisone - in terferon combination in the treatment of chronic hepatitis B: direct and indirect metaanalysis[J]. Hepatology, 1994,20: 1380- 1388.
10[8]Cooksley WG, Piraticsuth T, Wang YJ,et al. Forty- kda peginterferon alfa - 2a (pegasys: efficacy and safety results fvon a phase Ⅱ.randomised. actively controlled. Multicenter study in the treatment of HbeAg positive chronic hepatitis B (abstract) [J]. Hepatology, 2001,34: 349.
